Fermented Formula with Non-Digestible Oligosaccharides for Rotavirus Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas lack an effective composition to mimic the immunoprotective benefits of human milk against rotavirus infection, leading to severe diarrhea and growth issues in infants.
Innovation Solution
A nutritional composition that combines a fermented formula produced by lactic acid-producing bacteria with non-digestible oligosaccharides, enhancing the binding of rotavirus particles and gut barrier function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If infant formula is used as an alternative to human milk, then breastfeeding limitations are overcome, but the immunoprotective benefits against rotavirus infection are lost
Solution Approach 1:
The patent combines fermented formula containing postbiotic compounds with non-digestible oligosaccharides to create a composite nutritional composition that mimics the immunoprotective properties of human milk. This composite approach integrates multiple bioactive components that work synergistically to provide rotavirus protection, thereby resolving the contradiction between formula versatility and immunoprotective reliability.
2Reliability
If probiotics are added to infant formula, then immunomodulatory effects are achieved, but the complexity of formula composition increases
Solution Approach 1:
The patent transforms viable probiotics into postbiotic compounds through fermentation, changing the biological state from living organisms to metabolic byproducts. This parameter change simplifies the composition stability while maintaining immunomodulatory effects, as postbiotics do not require the same storage and handling conditions as live probiotics.
3Reliability
If fermented formula with postbiotic compounds is administered, then rotavirus binding is enhanced, but the severity of infection symptoms increases without non-digestible oligosaccharides
Solution Approach 1:
The patent merges fermented formula containing postbiotic compounds with non-digestible oligosaccharides to create a synergistic combination. The postbiotics provide direct rotavirus binding capability while the non-digestible oligosaccharides modulate the immune response and protect the intestinal barrier, together resolving the contradiction between enhanced virus binding and reduced infection severity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination significantly reduces the incidence, duration, and severity of rotavirus-induced diarrhea, and improves growth and development by enhancing gut barrier function and reducing viral load.
Implementation Method 1
a nutritional composition that is at least partly fermented by lactic acid producing bacteria
Implementation Method 2
enhancing the binding of rotavirus particles
Data Source
AI summary
Disclosed is a method for treating and/or preventing rotavirus infection in an infant or young child, and its related symptoms comprising administering a nutritional composition that is at least partly fermented by lactic acid producing bacteria and comprises non-digestible oligosaccharides.